Related Experiment Video
Updated: May 17, 2026
12:37
Modeling Colitis-Associated Cancer with Azoxymethane (AOM) and Dextran Sulfate Sodium (DSS)
Published on: September 11, 2012
[Pathogenesis of colitis-associated neoplasms].
1Institut für Pathologie, Klinikum Bayreuth GmbH, Preuschwitzer Str. 101, 95445 Bayreuth. pathologie@klinikum-bayreuth.de
Der Pathologe
|October 12, 2012
Summary
Distinguishing colitis-associated neoplasms from sporadic ones is now possible, aided by improved endoscopic and histological diagnosis of precursor lesions. Their distinct carcinogenesis pathways, involving different mutations and epigenetic changes, are detailed in this article, especially concerning ulcerative colitis.
Area of Science:
- Gastroenterology and Oncology
- Pathology
- Molecular Biology
Context:
- Distinguishing colitis-associated neoplasms from sporadic neoplasms presents diagnostic challenges.
- Recent advancements in endoscopic detection and histological diagnosis have increased the identification of precursor lesions like dysplasia and adenoma.
Purpose:
- To delineate the key differences in carcinogenesis between colitis-associated and sporadic neoplasms.
- To contextualize these differences within the framework of ulcerative colitis carcinogenesis.
Summary:
- Carcinogenesis in colitis-associated neoplasms differs fundamentally from sporadic neoplasms due to distinct genetic mutations and epigenetic alterations.
- The timing and nature of these molecular changes vary, impacting tumor development pathways.
- Improved diagnostic techniques enhance the detection of early neoplastic lesions in colitis patients.
Impact:
- Provides a clearer understanding of the distinct molecular mechanisms driving colitis-associated cancers.
- Aids clinicians in differentiating between colitis-associated and sporadic neoplasms.
- Informs targeted therapeutic strategies for neoplasms arising in the context of chronic colitis.
Related Concept Videos
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
01:26Inflammatory Bowel Disease I: Introduction
Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
01:26Gastritis II: Pathophysiology
The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...